✦ LIBER ✦

Concurrent Radiotherapy and Gemcitabine for Unresectable Pancreatic Adenocarcinoma: Impact of Adjuvant Chemotherapy on Survival

✍ Scribed by K. Ogawa; Y. Ito; N. Hirokawa; K. Shibuya; M. Kokubo; E. Ogo; H. Shibuya; K. Karasawa; K. Nemoto; Y. Nishimura

Book ID: 118456134
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 42 KB
Volume: 81
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2011.06.1817

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concurrent Radiotherapy and Gemcitabine

Concurrent Radiotherapy and Gemcitabine for Unresectable Pancreatic Adenocarcinoma: Impact of Adjuvant Chemotherapy on Survival

✍ Kazuhiko Ogawa; Yoshinori Ito; Naoki Hirokawa; Keiko Shibuya; Masaki Kokubo; Ets 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 271 KB

Phase I Study of Conformal Radiotherapy

Phase I Study of Conformal Radiotherapy and Concurrent Full-Dose Gemcitabine With Erlotinib for Unresected Pancreatic Cancer

✍ John M. Robertson; Jeffrey Margolis; Robert P. Jury; Savitha Balaraman; Matthew 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Survival benefits of adjuvant chemothera

Survival benefits of adjuvant chemotherapy with oral doxifluridine (5′-DFUR) following radiotherapy in patients with unresectable pancreatic cancer

✍ Koji Tsuruta; Astutake Okamoto; Naoto Egawa; Terumi Kamisawa; Katsuyuki Karasawa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

## Abstract ## Background and Objectives The combination of 5‐fluorouracil and radiotherapy is thought to be the most effective treatment for locally unresectable pancreatic carcinoma. The outcomes, however, are far from acceptable from the viewpoint of long‐term survival. We assessed the survival

Impact of Splenectomy on Thrombocytopeni

Impact of Splenectomy on Thrombocytopenia, Chemotherapy, and Survival in Patients with Unresectable Pancreatic Cancer

✍ Timothy R. Donahue; Kevork K. Kazanjian; William H. Isacoff; Howard A. Reber; O. 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 153 KB

6532 POSTER Phase I/II Study of Concurre

6532 POSTER Phase I/II Study of Concurrent Chemoradiotherapy With Gemcitabine and S-1 for Unresectable Locally Advanced Pancreatic Adenocarcinoma

✍ loka, T.; Arimoto, N.; Ashida, R.; Takakura, R.; Nakamura, S.; Nishiyama, K.; Ta 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

W1671 Prognostic Impact of Dihydropyrimi

W1671 Prognostic Impact of Dihydropyrimidine Dehydrogenase Expression in Adjuvant Gemcitabine Plus S-1 Chemotherapy After Surgical Resection for Pancreatic Adenocarcinoma

✍ Kondo, Naru; Murakami, Yoshiaki; Uemura, Kenichiro; Hayashidani, Yasuo; Sudo, Ta 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB